Home › Research › Treatments
Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial
Onder G, Zanetti O, Giacobini E, Frisoni GB, Frisoni GB, Bartorelli L, Carbone G, Lambertucci P et al.. The British journal of psychiatry : the journal of mental science, 2005-11-01
Topic: Amyloid, tau and blood-test diagnosis
Background Reality orientation therapy combined with cholinesterase inhibitors has not been evaluated in patients with Alzheimer's disease. Method We randomly assigned 79 of 156 patients treated with donepezil to receive a reality orientation programme. Caregivers of the treatment group were trained to offer the programme at home 3 days a week, 30 min/day, for 25 consecutive weeks, and were invited to stimulate and involve patients in reality-based communication.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Onder, G., Zanetti, O., Giacobini, E., Frisoni, G. B., Bartorelli, L., Carbone, G., et al. (2005). Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial. The British journal of psychiatry : the journal of mental science. https://doi.org/10.1192/bjp.187.5.450
Vancouver
Onder G, Zanetti O, Giacobini E, Frisoni GB, Bartorelli L, Carbone G, et al. Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial. The British journal of psychiatry : the journal of mental science. 2005. doi:10.1192/bjp.187.5.450. PMID: 16260821.
BibTeX
@article{onder2005-16260821,
author = {Onder, G. and Zanetti, O. and Giacobini, E. and Frisoni, G. B. and Bartorelli, L. and Carbone, G. and Lambertucci, P. and others},
title = {{Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial}},
journal = {The British journal of psychiatry : the journal of mental science},
year = {2005},
doi = {10.1192/bjp.187.5.450},
pmid = {16260821},
url = {https://doi.org/10.1192/bjp.187.5.450}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Method We randomly assigned 79 of 156 patients treated with donepezil to receive a reality orientation programme.
- Caregivers of the treatment group were trained to offer the programme at home 3 days a week, 30 min/day, for 25 consecutive weeks, and were invited to stimulate and involve patients in reality-based communication.
- Results The treatment group showed a slight improvement in Mini-Mental State Examination (MMSE) scores (mean change +0.2, s.e.=0.4) compared with a decline in the control group (mean change -1.1, s.e.=0.4; P=0.02).
- Similarly for the Alzheimer's Disease Assessment Scale--Cognition (treatment group mean change +0.4, s.e.=0.8; control group -2.5, s.e.=0.8; P=0.01).
Why it matters
In this randomized trial, 79 of 156 patients taking donepezil for Alzheimer's disease received a reality orientation programme at home for 25 weeks, and the treatment group showed a slight MMSE improvement compared with a decline in controls. This suggests a possible small benefit from combining reality orientation with cholinesterase inhibitors, but it does not indicate a cure or prevention.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Participants156
- Evidence strengthLow
How this study scored 60/100
Published in a peer-reviewed journal, and it is a randomised controlled trial. Scored zero for effect reported because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (The British journal of psychiatry : the journal of mental science) |
| Journal's citation record | 3 / 4 | The British Journal of Psychiatry: journal h-index 376 (OpenAlex, 2026-10-29) |
| Study design | 11 / 12 | A randomised controlled trial (from PubMed type “Randomized Controlled Trial”) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2005 — older than 20 years, still counted |
| Sample size | 2 / 4 | 156 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomised / blinded | 1 / 2 | Randomised (as stated in the record) |
| Times cited | 5 / 7 | Cited 151 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 6.6 citations a year over 23 year(s) since 2005 |
| Impact for its field and year | 2 / 6 | Cited 1.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 8 other studies in this library |
| Still being cited | 1 / 4 | Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Roberto Bernabei: h-index 113 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Geneva: institution h-index 1,049 (OpenAlex) |
| Multi-centre collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 16260821) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 60 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1192/bjp.187.5.450
- PubMed: 16260821
- Original source →
- Free full text: The British Journal of Psychiatry →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
8 studies in the alzhub library list this one in their references.
Related studies in Treatments
Also tagged “placebo-controlled”
783 studies in the library carry the topic tag “placebo-controlled”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.